Cerus (CERS) EBITDA Margin (2010 - 2026)
Cerus (CERS) reported EBITDA Margin of -2.43% for Q2 2026, up 3.44 percentage points from -5.87% a year earlier but down 2.61 percentage points from the prior quarter.
Powered by 
Analysis
Cerus (CERS) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cerus' EBITDA Margin came in at -4.21%, up 6.35 percentage points year-over-year; for FY2021, it came in at -28.70%, up 19.63 percentage points from FY2020.
- EBITDA Margin has increased for six consecutive years, with a five-year change of +123.12 percentage points (FY2016 to FY2021).
- By year, EBITDA Margin came in at -48.34% in FY2020 (+19.72 pp), -68.06% in FY2019 (+2.34 pp), -70.40% in FY2018 (+38.15 pp) and -108.56% in FY2017 (+43.27 pp).
- Five-year quarterly EBITDA Margin spans a low of -24.61% in Q3 2021 and a high of 0.17% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.62% |
| 10 | Cerus | 497.77 Mn | 200.38 Mn | 29.53 Mn | -2.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.43% |
| Mar 31, 2026 | 0.17% |
| Jun 30, 2025 | -5.87% |
| Mar 31, 2025 | -12.83% |
| Sep 30, 2022 | -14.54% |
| Jun 30, 2022 | -12.75% |
| Mar 31, 2022 | -20.88% |
| Dec 31, 2021 | -12.28% |
| Sep 30, 2021 | -24.61% |
| Jun 30, 2021 | -36.08% |
| Mar 31, 2021 | -52.94% |
| Dec 31, 2020 | -40.28% |
| Sep 30, 2020 | -45.12% |
| Jun 30, 2020 | -51.54% |
| Mar 31, 2020 | -59.64% |
| Dec 31, 2019 | -59.59% |
| Sep 30, 2019 | -74.78% |
| Jun 30, 2019 | -67.90% |
| Mar 31, 2019 | -71.44% |
| Dec 31, 2018 | -47.75% |
API Access
Cerus EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();